Chicago health-tech executives convicted of overbilling clients and misleading lenders
Outcome Health · Healthcare advertising technology (private)
The case in brief
Visible before detection
Checks that could have surfaced it, on hindsight
Operating-metric verification
Would have compared billed impressions with device logs from the tablets.
Can mislead when: Contract staff do not appear in EPFO. Vahan access needs licensed APIs. Some businesses have no physical trace.
Third-party confirmation
Would have asked pharma clients to confirm campaigns delivered.
Can mislead when: Counterparties can collude or ignore requests. A non-response is logged as a gap, never as a pass.
End-use tracing of funds
Would have traced how much of the raised debt paid founder dividends.
Can mislead when: Kubr sees only the company's own accounts. Once money reaches a third party's bank, Kubr can flag the payee but cannot see the next hop without that party's consent.
Where Kubr services would have helped
Valuation context
Offered in India- Peer multiples and the exit-multiple bridge would have shown how much of the story relied on valuation holding.
Proceeds tracer
Offered in India- C6 Would have traced how much of the raised debt paid founder dividends.
- C10 Would have compared billed impressions with device logs from the tablets.
Financial diligence
Offered in India- C10 Would have compared billed impressions with device logs from the tablets.
Model check
Offered in India- C10 Would have compared billed impressions with device logs from the tablets.
Mapped from the checks each service runs. A hindsight reading of public records, not a promise that the failure would have been found.
Same pattern
A summary of public documents. It reports what the sources say. It is not Kubr's finding and not a statement of guilt.